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CS (chondroitin sulfate) is a glycosaminoglycan species that is
widely distributed in the extracellular matrix. To understand the
physiological roles of enzymes involved in CS synthesis, we
produced CSGalNAcT1 (CS N-acetylgalactosaminyltransferase
1)-null mice. CS production was reduced by approximately
half in CSGalNAcT1-null mice, and the amount of short-chain
CS was also reduced. Moreover, the cartilage of the null mice was
signiﬁcantly smaller than that of wild-type mice. Additionally,
type-II collagen ﬁbres in developing cartilage were abnormally
aggregated and disarranged in the homozygous mutant mice.
These results suggest that CSGalNAcT1 is required for normal
CS production in developing cartilage.
Key words: cartilage, chondroitin sulfate, collagen ﬁbre,
N-acetylgalactosaminyltransferase (GalNAcT), gene knockout,
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INTRODUCTION
CS (chondroitin sulfate) is a type of GAG (glycosaminoglycan),
which are present in the extracellular matrices and on the
surface of many cell types [1]. Similar to other GAGs, CS
is attached to a serine residue of the core protein to form
the CSPG [CS PG (proteoglycan)] [1]. After the formation of
a common linkage region (GlcUAβ1-3Galβ1-3Galβ1-4Xylβ1-
O-Ser) between sugar chains and the core protein, repeating
disaccharide units of GalNAc (N-acetylgalactosamine) and
GlcUA (glucuronic acid) residues with interspersed sulfate
residues are synthesized [1]. Thus biosynthesis of a CS-speciﬁc
polysaccharide chain is initiated by the transfer of a GalNAc
residue to the tetrasaccharide linker, followed by the addition of
GlcUA and GalNAc residuesin reiterative chain elongation steps.
There are six glycosyltransferases known to be involved
in CS synthesis [2–10]. Among them, CSGalNAcT1 (CS
N-acetylgalactosaminyltransferase-1) and CSGalNAcT2 each
have one glycosyltransferase domain, exhibit GalNAc transfer
activity in both the initiation and elongation processes, and are
thought to be responsible for the addition of the ﬁrst GalNAc
residue to the tetrasaccharide chain [4–7]. Although each of the
six enzymes has been characterized biochemically in in vitro
studies, the mechanism of in vivo CS biosynthesis, including
roles for each glycosyltransferase, is poorly understood. Since
cartilage contains the largest amount of CS of all body tissues,
chondrocytes efﬁciently synthesize CS chains [11,12]. CS in
cartilage is selectively linked to aggrecan, which can possess
more than 100 CS chains; these CSPGs subsequently form
multimolecular aggregates through interaction with hyaluronate
and linker proteins [13]. CSGalNAcT1 is highly expressed in the
developing cartilage, and this enzyme is thought to play a crucial
role in CS biosynthesis on the basis of a study using cell lines
[14]. Moreover, CSGalNAcT1 is thought to have important roles
in chondrogenesis at early developmental stages [14].
To investigate the physiological role of CSGalNAcT1 in CS
biosynthesis, we produced CSGalNAcT1-null mice and analysed
the morphologyand biochemistry of developing cartilage in these
mutants. The mice were viable and fertile; however, the amount
of CS was reduced by half relative to the amount in wild-type
controls, and the null mice showed an abnormal proﬁle of GAG
chains in the biochemical analysis of CS. The thickness of the
epiphysealcartilagelayerwasdecreasedby25%atE(embryonic
day)18.5.Moreover,thehindlimbandthebodywerealsoshorter.
Taken together, our data suggest that CSGalNAcT1 plays a role
in CS synthesis in the cartilage during embryonic development.
EXPERIMENTAL
Materials
ProteusvulgarischondroitinaseABC(EC4.2.2.4)waspurchased
from Seikagaku. The Superdex
TM 200 10/300 GL column was
obtained from Amersham Pharmacia Biotech.
Abbreviations used: 2-AB, 2-aminobenzamide; C4st-1, chondrotin 4-sulfotransferase-1; ChPF, chondroitin polymerization factor; ChSy, chondroitin
synthase; CS, chondroitin sulfate; CSGalNAcT, chondroitin sulfate N-acetylgalactosaminyltransferase; CSPG, chondroitin sulfate proteoglycan; E,
embryonic day; ES, embryonic stem; Fam20b, family member 20B; G3pdh, glyceraldehyde-3-phosphate dehydrogenase; GAG, glycosaminoglycan;
GlcUA, glucuronic acid; HRP, horseradish peroxidase; PCNA, proliferating cell nuclear antigen; PG, proteoglycan; RT, reverse transcription; TEM,
transmission electron microscope.
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Generation of CSGalNAcT1-null mice
All animal experiments were carried out in accordance with
the guidelines laid down by the animal welfare committees of
Niigata University. The CSGalNAcT1-null mice were produced
by homologous recombination using a new ES (embryonic stem)
cellline,RENKA,whichwedevelopedfromtheC57BL/6N strain
[15].
The mouse CSGalNAcT1 gene (chondroitin 4-sulfotransferase-
1)wasidentiﬁedbyhomologywiththehumanCSGalNAcT1gene
(GenBank® accesion number NM_172753) [encoding 530 amino
acids; 89% identity and 92% similarity to human EC 2.4.1.174
(NM_001130518)]. A 1.8-kb DNA fragment, which carried
the 34-bp loxP sequence and Pgk-1 promoter-driven neomycin
phosphotransferase gene (neo) ﬂanked by two Flp recognition
target (frt) sites [16], was inserted into a site 372 bp upstream of
exon 7. The 34-bp loxP sequence was inserted into a site 249 bp
downstream of exon 6. The targeting vector, ptv CSGALNACT1-
ﬂox, contained exon 7 of the CSGalNAcT1 gene ﬂanked by loxP
sequences, genomic sequences from 3.4 kb upstream and 7.1 kb
downstream of exon 6, and a 4.3 kb pMC1DTpA vector [17].
ES cells were cultured on mitomycin C-treated neomycin-
resistant ﬁbroblasts in DMEM (Dulbecco’s modiﬁed Eagle’s
medium; high glucose; Invitrogen) supplemented with 17.7%
ES-cell-qualiﬁed fetal bovine serum (Invitrogen), 88.4 μM non-
essential amino acids (Invitrogen), 884 μM sodium pyruvate
(Sigma), 88.4 μM 2-mercaptoethanol (Sigma) and 884 units/ml
of murine leukaemia inhibitory factor (ESGRO; Chemicon
International). Linearized targeting vector was electroporated
into RENKA cells, and G-418 (175 μg/ml)-resistant clones
were picked. Recombinant clones were identiﬁed by Southern
blot hybridization analysis. Recombinant ES cells were injected
into eight-cell-stage embryos of the CD-1 mouse strain. The
embryos were cultured to blastocysts and transferred to the
uterus of a pseudopregnant CD-1 mouse. Resulting chimaeric
mice were mated to C57BL/6N mice, and heterozygous offspring
[CSGalNAcT1
+/ﬂoxneo] were mated to telencephalin-cre mice
[18,19]. The resulting heterozygous (CSGalNAcT1
+/−; Cre
+/−)
mice were mated with C57BL/6N mice and the mice without the
Cre gene were selected. Homozygous mutant mice and control
mice were obtained by crossing heterozygous pairs.
Genotypes of the CSGalNAcT1
+/ﬂoxneo mice and
CSGalNAcT1
+/− mice were identiﬁed by Southern blot hybridi-
zation analysis. Elimination of the Cre gene was conﬁr-
m e db yP C Ru s i n g5
 -GCCTGCATTACCGGTCGATGC-
AACG-3
  (CreP1) and 5
 -GCCCGGACCGACGATGAAGCAT-
GTT-3
  (CreP2) [20] with internal control primers 5
 -CCAGC-
TCCAGGGATCTAACA-3
  and 5
 -ATTAAGGGCCAGCTCAT-
TCC-3
  (glutamate receptor GluN2A subunit). Routine
genotyping of CSGalNAcT1
+/− animals was conducted by PCR
using the primers 5
 -CCAGCTCCAGGGATCTAACA-3
  and
5
 -TGGTTTCCTCTAGCCATTGC-3
 .
Derivatization of CS from articular cartilage using a ﬂuorophore,
2-AB (2-aminobenzamide)
Articular cartilage CSPG from E18.5 embryos was extracted
with 4 M guanidinium chloride and 0.05 M Tris/HCl, pH 8.0,
containingproteinaseinhibitorsasdescribed[21].Theextractwas
centrifuged at 15000 g for 10 min to remove insoluble material.
The protein concentration of each sample was determined using
a BCA (bicinchoninic acid) protein assay kit (Thermo Fisher
Scientiﬁc) according to the manufacturer’s instructions. The
CSPG fractions were precipitated with 70% ethanol containing
5% sodium acetate. The partially puriﬁed CSPG fraction was
digested with chondroitinase ABC, and the digests were then
derivatized with 2-AB and analysed by HPLC as previously
described [22].
Gel-ﬁltration chromatography of CS
To determine the chain length of CS, the puriﬁed CSPG fraction
was subjected to reductive β-elimination using NaBH4/NaOH,
and then analysed by gel-ﬁltration chromatography on a column
(10 × 300 mm) of Superdex 200 eluted with 0.2 M ammonium
bicarbonate at a ﬂow rate of 0.4 ml/min. Fractions were collected
at 3 min intervals, lyophilized and digested with chondroitinase
ABC. The digests were derivatized with 2-AB, and then analysed
byHPLConanamine-boundPA-03column[22].Theamountsof
the2-ABderivativesofunsaturateddisaccharideswerecalculated
based on ﬂuorescence intensity.
Quantitative real-time RT (reverse transcription)–PCR
Total RNA was extracted from articular cartilage using
RNeasy Lipid Tissue Mini kit (Qiagen) according to the
manufacturer’s instructions. The cDNA was synthesized from
∼1 μg of total RNA using Moloney-murine-leukaemia virus
reverse transcriptase (Promega) and an oligo(dT)20-M4 adaptor
primer (Takara). The primer sequences used were as follows:
CSGalNAcT1, forward primer 5
 -CCAATTTCAGAAACTT-
CACCTTCAT-3
  and reverse primer 5
 -TGTTCAGCCTACAA-
GTGTTGAG-3
 ; CSGalNAcT2, forward primer 5
 -TTAATATC-
ATTGTGCCACTTGCG-3
  and reverse primer 5
 -TAGAATA-
GACTTGACTTTAGATAGTCCTT-3
 ; C4st-1 (chondroitin
4-sulfotransferase-1), forward primer 5
 -ACCTCGTGGGCAA-
GTATGAG-3
  and reverse primer 5
 -TCTGGAAGAACTCCGT-
GGTC-3
 ;Fam20B(familymember20B)[23],forwardprimer5
 -
TTGTCTTTAAGCCTAAGCGGT-3
  and reverse primer 5
 -GG-
CTTAACTTCTGTCCGCA-3
 ;a n dG3pdh (glyceral-
dehyde-3-phosphate dehydrogenase), forward primer 5
 -CAT-
CTGAGGGCCCACTG-3
  and reverse primer 5
 -GAGGCCAT-
GTAGGCCATGA-3
 . Quantitative real-time RT–PCR was
performed using a FastStart DNA Master plus SYBR Green
I (Roche Diagnostics) in a LightCycler ST300 (Roche
Diagnostics). The expression levels of CSGalNAcT1,
CSGalNAcT2, C4st-1 and Fab20B mRNA were normalized
to that of the G3pdh transcript.
Western blot analysis with anti-CSGalNAcT1 antibody
The anti-CSGalNAcT1 antibody was generated against recom-
binantGST(glutathionetransferase)–CSGalNAcT1(aminoacids
261–534). E18.5 cartilage and brain extracts (0.1 mg of total
protein) were subjected to SDS/PAGE (10% gels), followed by
immunoblot analysis.
Body length and weight
Measurements were performed on adults from the dorsal tip of
the nose to the dorsal base of the tail while mice were under
anaesthesia. The body weight and body length measurements
were based on data from seven male offspring from seven unique
litters. Statistical analysis was performed using a Student’s t test
and the data are represented as the means+ −S.E.M. *P<0.05.
Skeletal analysis
Embryos were eviscerated under anaesthetic (isoﬂurane or
pentobarbital) and ﬁxed in 100% ethanol for 4 days. Toluidine
Blue staining was performed in a solution of 80% ethanol,
20% acetic acid and 0.015% Toluidine Blue for 4 days at
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Figure 1 CSGalNAcT1-null mice did not express the CSGalNAcT1 enzyme
(A)ConstructofthetargetingvectorforproducingtheCSGalNAcT1-nullmice.Thenumbersrepresenttheexonnumber(exon1isdeﬁnedastheﬁrstexonofthisgenewherethetranscriptionstarts).
RV, EcoRV site; S, ScaI site. (B) Immunoblot analysis using an anti-CSGalNAcT1 antibody to probe head homogenate from wild-type mice (lane 2), heterozygous (CSGalNAcT1+/−) mice (lane 3)
and null mice (CSGalNAcT1−/−) at E18.5. Lane 1 shows the negative control (wild-type homogenate after absorption by the recombinant CSGalNAcT1 protein). Note that no reactivity was evident
in the homogenate from null mice (lane 4). (C) RT–PCR analysis of genes encoding several enzymes involved in CS synthesis. The expression level is shown as a ratio of each gene to G3pdh for
normalization. Fam20B is an enzyme that phosphorylates xylose [23]. Note that no other speciﬁc enzymes showed elevated expression to compensate for the loss of CSGalNAcT1 protein.
37◦C. Specimens were rinsed and soaked in 100% ethanol for
3 days. Alizarin Red staining was then performed in a solution of
0.002%AlizarinRedand1%KOHfor12 hatroomtemperature
(25◦C). After rinsing with water, specimens were kept in 1%
KOH solution until the skeletons become clearly visible. For
storage,specimensweretransferredsequentiallyinto50%,80%,
and ﬁnally 100% glycerol. Tibial length was determined by
measuring the distance between the proximal and distal articular
surfaces with a ruler under light microscopy.
Thickness of epiphyseal cartilage
To compare the thickness of epiphyseal cartilage of proximal
femurs, formalin-ﬁxed and parafﬁn-embedded bones of the limbs
from E18.5 and at 4 weeks of postnatal development were used.
The tissue material was sliced into serial sections and stained
with haematoxylin/eosin. AnSZX16microscope (Olympus) with
a digital camera Axiocam HRc (Zeiss) was used to collect image
data from the serial sections, and the thickness of the epiphyseal
cartilage was calculated from the length of the longitudinal centre
axis by Imaris (Zeiss) and ImageJ (National Institutes of Health).
A double-blind histological comparison between the null and the
wild-typemicewasperformed.AMann–WhitneyU testwasused
to analyse the data.
Tissue preparation for mouse specimens
Mice were anaesthesitized with diethyl ether and pento-
barbital (Nembutal; Dinabot) and then perfused with 4%
paraformaldehyde solution (pH 7.4) under anaethestia tibiae
of E18.5 CSGalNAcT1
−/− fetuses were extracted, decalciﬁed,
and embedded in parafﬁn as previously described [24].
ImmunostainedsectionsofthemicewereobservedunderaNikon
Eclipse E800 microscope, and light microscopic images were
acquired with a digital camera (Nikon DXM1200C). For TEM
(transmissionelectronmicroscope)observations,ﬁxedspecimens
were decalciﬁed, post-ﬁxed with osmium tetroxide, dehydrated,
and embedded in epoxy resin (Epon 812) as previously described
[10]. Ultra-thin sections were obtained with an ultra microtome
(Sorvall MT-5000) and stained with an aqueous solution of 1%
tannic acid, 4% uranyl acetate and 2% lead citrate. These
specimens were observed using a TEM (Hitachi H-7100) at
80 kV.
Immunostaining for type-II collagen and PCNA (proliferating cell
nuclear antigen)
Dewaxed parafﬁn sections were pre-treated for endogenous per-
oxidaseinhibition with 0.3% H2O2 in PBS for20 minandtreated
as described previously with a 0.5% hyaluronidase solution
(type I-S, from bovine testis; Sigma) for 10 min [24]. They were
subjected to blocking for non-speciﬁc binding with BSA/PBS
(1% BSA in PBS) for 30 min at room temperature. Sections
were then incubated with rabbit anti-type-II or type-X collagen
(1:100; LSL) overnight at 4◦C followed by incubation with HRP
(horseradish peroxidase)-conjugated anti-(rabbit Igs) (Chemicon
International) overnight at 4◦C. Other sections were incubated
with mouse monoclonal antibody against PCNA (Oncogene),
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Figure 2 CS production in cartilage is reduced in CSGalNAcT1-null mice
(A) The total amount and disaccharide analysis of the cartilage in wild-type (Wt), heterozygous (+/−; CSGalNAcT1+/−) and null (−/−; CSGalNAcT1−/−) mice. Student’s t test was performed to
comparethedisaccharideamountderivedfromCSinthenullmicewiththatinthewild-typeortheheterozygousmice.Resultsareshownasmean+ −S.E.M.*P < 0.05;**P < 0.01(n=6). di-0S,
 HexAα1-3GalNAc; di-4S, HexAα1-3GalNAc(4S); di-6S,HexAα1-3GalNAc(6S).(B)ToluidineBluestainingoftheepiphysealcartilagefromE18.5wild-type(Wt;left)andCSGalNAcT1-null
(−/−) fetuses. Metachromasia of Toluidine Blue (purple colour) can be seen in the wild-type cartilage, whereas no metachromasia is discernible in the null mice cartilage. Note the reduced size of
the epiphyseal cartilage in the null mice, compared with their wild-type counterpart (bidirectional arrows, upper panels). The extracellular spaces in the cartilage of null mice have many spicules
(arrows, lower panels), whereas the intercellular regions from wild-type mice do not. pro, proliferative zone; hyp, hypertrophic zone. Scale bars: in upper panels, 200 μm; in lower panels, 50 μm.
(C) Gel-ﬁltration analysis of the length of CS sugar chains in the E18.5 cartilage in wild-type (), heterozygous (CSGalNAcT1+/−;) and null (CSGalNAcT1−/−;) mice. There are no signiﬁcant
differences in the total amount of CS loaded on to the gels among groups. Note that the second peak between fraction numbers 30 and 35 is present both in wild-type and heterozygous mice, but
not in CSGalNAcT1-null mice, indicating that the size of the GAG chains of CS changed in CSGalNAcT1-null mice. Arrowheads indicate the size of the molecular-mass-marker standards [mean
molecular masses (K, kDa): 200, 65.5, 37.5 and 18.1 respectively; all from Sigma]. The calibration of the Superdex 200 column was performed using a series of size-deﬁned commercial dextran
polysaccharides. The results shown represent one of three series of independent experiments, where the three series of experiments gave essentially identical results.
followed by incubation with HRP-conjugated anti-(mouse IgG)
(Chemicon).Visualizationoftheimmunecomplexwasperformed
with diaminobenzidine tetrahydrochloride. All sections were
faintly counterstained with Methyl Green.
RESULTS
ToinvestigatetheroleofCSsynthesisinskeletaldevelopment,we
inactivated the CSGalNAcT1 gene by targeted gene replacement
in ES cells and subsequent gene knockout in transgenic mice.
The DXD motif is present in most GalNAc/Gal transferases and
is essential to the in vitro activity of these enzymes as the binding
site for divalent metal cations such as Mn
2+ [25–27]; therefore
we focused on this motif in our gene targeting and gene knockout
strategy. Since mouse CSGalNAcT1 has a DXD motif that is
encoded in exon 7, we designed the targeting vector with exon
7 located between two loxP sites. Speciﬁcally, the neomycin-
resistance cassette (neo-cassette) was inserted adjacent to exon 7
(Figure1A).AftertheCrerecombinase-dependentexcisionofthe
exonic sequences ﬂanked by loxP sites, a frame shift occurs that
should prevent the production of normal CSGalNAcT1 enzyme
(Figure 1A).
The vector was introduced into the C57BL/6 ES cells, and
chimaeric mice containing clonal recombinant ES cells were cro-
ssed with C57BL/6 mice. The complete null mice were obtained
by mating the ﬂoxed mouse with a telencephalin-Cre mouse that
expressed the Cre-recombinase in all cell types of early stage
embryos (Figure 1A) [19].
The CSGalNAcT1 protein and CSGalNAcT1 mRNA was
completely absent from CSGalNAcT1-null mice based on
immunoblotting (Figure 1B) and RT–PCR (Figure 1C) analyses
respectively. The CSGalNAcT1-null mice were viable and
fertile. The protein and mRNA levels in heterozygous mice
(CSGalNAcT1
+/−) were decreased to 38% and 40% respectively
of those in the wild-type controls (Figures 1B and 1C). Other
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Figure 3 CSGalNAcT1-null mice have reduced skeletal growth
(A andB)Thebodyweight(A)andthebodylength(B)in thewild-type()a ndCSGalNAcT1-nullmice () duringpostnataldevelopment.At 4weeksafter birth,thebodymassandthebodylength
of the null mice were slightly reduced compared with those of the wild-type.*P <0.05 (Student’s t test). (C) The fetal body (top panel) and skeleton (bottom panel) of wild-type (Wt), heterozygous
(+/−) and null (−/−) mice. (D) Various bone segments of the fetal mice. Note that only forelimb bones of the null mice are shorter than those of wild-type mice. (E) Measurements of femur length.
The femurs at E18.5 of the null mice are signiﬁcantly shorter than those of wild-type and heterozygous mice (Student’s t test; P <0.00001). The number of the femurs measured for each genotype is
shown in parentheses. The results are shown as means+ −S.E.M.
enzymes related to CS synthesis, including CSGalNAcT2,
a paralogue of CSGalNAcT1, were not up-regulated in
the CSGalNAcT1-null mice (Figure 1C), indicating that no
compensatory elevation in expression of related enzymes
occurred.
The null mice were viable and fertile; however, we found a
large number of abnormalities in the cartilages of these mice. CS
productioninthecartilageofheterozygousmice(64.4+ −5.3nmol/
mg of protein) was not reduced compared with that of wild-
type mice (63.0+ −4.4 nmol/mg of protein); however, total CS
content in CSGalNAcT1-null mice was less than half (31.0+ −3.0
nmol/mg of protein; n=6 of each; Figure 2A) of that in the
wild-type controls. Normally, CS appears metachromatically
violet in Toluidine Blue-stained samples. On the basis of
Toluidine Blue staining, the cartilage of wild-type controls was
enriched with CS, and the metachromasia indicative of CS
was not observed in the CSGalNAcT1-null mice (Figure 2B).
Consistent with observation of aggregated collagen ﬁbres under
electron microscopic observation, there were many speculate
ﬁbres in the CSGalNAcT1-null mice (see arrows in Figure 1B;
also see below and Figure 5). CS in the null mice was
compositionally similar to that in the control mice except for
a reduction in the proportion of the non-sulfated disaccharide
(Figure 2A).
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Figure 4 The thickness of the growth plate is reduced in CSGalNAcT1-null mice
(A) Histological views of the epiphyses of E18.5 wild-type (Wt)a n dCSGalNAcT1-null (−/−) mice. Upper panels: hind limbs (f,f e m u r ;t, tibia), middle panels: the femurs of these littermates; lower
panels: higher magniﬁcation views of the middle panels focusing on the epiphyseal cartilage. Consistent with the decreased size of femurs and tibiae of the null mice, the femoral epiphyseal cartilage
(epi) was reduced in size in null mice compared with that of their wild-type counterparts. Scale bar: upper panels, 1 mm; middle panels, 500 μm; lower panels, 300 μm. (B) Histological ﬁndings on
the growth plates of 4-week-old wild-type (Wt) and null (−/−) mice. Upper and lower panels show lower and higher magniﬁcation respectively. The longitudinal length of the growth plates (GP)
was shortened in the null mice (bidirectional arrows, lower panels). Scale bars: upper panels, 800 μm; lower panels, 200 μm. (C and D) Immunodetection of type-II (II; upper panels) and type-X (X;
lower panels) collagen in the epiphyses of the wild-type (Wt) and null (−/−) E18.5 fetuses (C) and 4-week-old mice (D). In (C), the type-II collagen-positive area (brown) was seen throughout the
epiphyses of both Wt and null mice, despite the ﬁnding that cartilage area of the null mice was reduced (upper panels). Even in (D), the reduced size of the type-II collagen reactive-growth plate in
the null mice was observed. Judging from the hypertrophic zone marker type-X collagen immunostaining, cartilage from E18.5 (C) and four-week-old (D) animals had a reduced hypertrophic zone.
Scale bars: (C), 300 μm; (D), 100 μm. (E) Quantitative measurement of the epiphyseal cartilage in area. Both E18.5 and 4-week-old (4w) femurs were collected. (Mann–Whitney U test; P < 0.05).
The results are shown as means+ −S.E.M.
Using gel ﬁltration, we determined the size of the CS chains
(Figure 2C). Unexpectedly, the CS chains from the cartilage
in CSGalNAcT1-null mice were not the same in size as those
from cartilage of wild-type or heterozygous mice. Speciﬁcally,
CS chains of different lengths in the developing cartilage
were identiﬁed as individual peaks in samples from wild-type
mice (Figure 2C, closed circle). The longest CS chains were
preserved in the null mice, but the amount of shorter chains was
signiﬁcantly reduced relative to the amount in wild-type animals
(Figure 2C).
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The CSGalNAcT1-null mice had a slightly but signiﬁcantly
shorter mean body length and smaller mean body weight than the
wild-type controls (Figures 3A–3C); these differences were most
likely due to the shorter limbs and axial skeleton of the null mice
(Figure3D).Incontrast,theskullsofthemutantmiceweresimilar
in circumference and body weight to those of the heterozygous
and wild-type mice (Figure 3D). The null mice had femurs that
were 10% shorter than those of wild-type and heterozygous mice
on E18.5 (Figure 3E).
The epiphyseal cartilage of the femur in the CSGalNAcT1-
null mice was apparently thinner than that of wild-type mice at
E18.5 (Figure 4A). Type-II collagen staining also clearly showed
thinning of the cartilage in the null mice (Figure 4C). At 4 weeks
of postnatal development, the growth plate in null mice was still
smaller than that in the wild-type animals (Figures 3B and 3D).
In the null mice, the area of type-X collagen immunostaining,
a marker of the hypertrophic zone in cartilage, was slightly
smaller than that of wild-type animals at E18.5 and after 4 weeks
of postnatal development (Figures 4C and 4D). The cartilage
thickness at E18.5 was 25% narrower in CSGalNAcT1-null mice
than in wild-type animals (Figure 3E). After 4 weeks of postnatal
development, the cartilage of the null mice was still 15% thinner
than that of the wild-type controls (Figure 4E). Staining for the
cell proliferation marker PCNA was similar in chondrocytes of
wild-type and null mice (results not shown), indicating that cell
proliferation is not impaired in CSGalNAcT1-null mice and is not
the cause of the cartilage abnormalities in the mutant animals
(Figures 4C and 4D).
The extracellular matrix of cartilage is composed of two major
structural components: collagen ﬁbres and PG aggregates [12].
We examined the ultrastructure and arrangement of the collagen
ﬁbres in CSGalNAcT1-null mice using electron microscopy.
Type-II collagen ﬁbres were abnormally aggregated in the
proliferative and resting layers of the cartilage (Figures 5A–
5D). The ﬁbres were thickened and convoluted in the cartilage
substance(Figure5F).Theaggregatedcollagenﬁbresappearedto
be associated with the chondrocytes of the null mice (Figure 5D),
and this arrangement was not observed in wild-type tissue
(Figures5A,5Cand5E).TheseresultsindicatethatCSGalNAcT1
is important in establishing and/or maintaining normal cartilage
ultrastructure including the arrangement of collagen ﬁbres and
the CSPG matrix.
DISCUSSION
In the present study, we demonstrated that CSGalNAcT1 is
one of the key enzymes for CS biosynthesis in skeletal and
cartilage development in vivo by generating and analysing
CSGalNAcT1-null mice. The speciﬁc substrates of CS-
synthesizing glycosyltransferases, including CSGalNAcT1, are
ﬁrmly established based on in vitro studies [9,10,14]; however,
no previous report deﬁnitively addresses the in vivo physiological
function of any enzyme involved in CS synthesis. In the
present study, we make two observations in CSGalNAcT1-null
mice: (i) abnormalities in CS biochemistry; and (ii) defects in
cartilage development, suggesting that this enzyme is essential
for normal cartilage development and normal CS synthesis.
During the early stages of embryonic cartilage development,
this enzyme was required for at least 50% of the total CS
synthesis (Figure 4A), indicating that other enzymes [5,7]
cannot fully compensate for the absence of this enzyme
(Figure 2B). CSGalNAcT1 is highly expressed in developing
cartilage [14]; thus CSGalNAcT1 does have a non-redundant
role in CS synthesis. The remaining 50% of CS synthesis in
cartilage is probably dependent upon the activities of ChSy-1
Figure 5 Abnormal ultrastructure of the type-II collagen is frequently
observed in cartilage and chondrocytes of CSGalNAcT1-null mice
(A, C and E) Wild-type (Wt) mice; (B, D and F) CSGalNAcT1-null (−/−) mice; at E18.5.
Micrographs (A)a n d( B) were obtained from the resting zone, and (C)a n d( D)f r o mt h e
proliferative zones. Note that many electron-dense extracellular ﬁbrils (arrows) are seen
connecting chondrocytes in the resting (B) and proliferative (D) zones of the epiphysis from
null mice, whereas only a few such ﬁbrils are observed in both zones (A; resting zone, and C;
proliferativezone)ofwild-typemice.Atahighermagniﬁcation,thewild-typecartilagematrixhad
collagen ﬁbrils that spread radially (E), whereas cartilage of the null mice had a ﬁne meshwork
of twisted cartilaginous ﬁbrils (F). Ch, chondrocytes. Scale bars: (A)–(D), 10 μm; (E)–(F),
1 μm.
(chondroitin synthase 1), ChSy-3 and ChPF (chondroitin
polymerization factor) because they are expressed at high levels
in this tissue, and any combinations of two of these enzymes can
catalyse chondroitin polymerization in in vitro experiments [3,9].
CSGalNAcT2 is much less abundant than CSGalNAcT1, ChSy-
1, ChSy-3 or ChPF in cartilage; thus we believe that ChSy-1,
ChSy-3 and ChPF contributed more signiﬁcantly to CS synthesis
than CSGalNAcT2 did in the CSGalNAcT1-null mice [14];
however, it is possible that CSGalNAcT2 was more active than
ChSy-1, ChSy-3 or ChPF in CS chain elongation rather than
initiation of CS synthesis in cartilage of CSGalNAcT1-null mice.
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These results also indicate that CSGalNAcT1 may be required
for the production of speciﬁc short-chain CS species (Figures 2C
and 2D). This is probably because CS GAG chains are
synthesized differently depending upon the linkage position
on the core protein, aggrecan. Other previous in vitro studies
have demonstrated that CSGalNAcT1 and other CS-synthesizing
enzymes have complex speciﬁcities, and these enzymes are
thought to recognize the complicated three-dimensional structure
of the sugar–core protein linkage to produce CS GAG chains
in vivo [5,9]. However, it is also possible that the number of
CS chains is determined by the level of initiating CSGalNAcT
enzymes in the wild-type mice, but that chain length may be
limited, to some extent, by availability of sugar precursors and/or
elongating enzyme, leading to some different-sized chains in
CSGalNAcT1-null mice. Further studies using these mice are
needed to clarify the exact in vivo mechanisms that results in
the absence of shorter CS chains in CSGalNAcT1-null mice.
The exact reason for the delay in cartilage development in
the CSGalNAcT1-null mice is unknown [28]; however, it has
been suggested that Indian Hedgehog and FGF (ﬁbroblast growth
factor), key signal molecules operating in early growth plate
development, interact with CS [29]. Thus it is likely that the
reduction of CS could affect normal chondrogenesis. In addition,
type II collagen ﬁbres in the cartilage of CSGalNAcT1-null mice
also showed abnormal aggregation, probably due to a reduction
in CS (Figure 5), indicating that this enzyme also affects the
ultrastructure of cartilage during development. Since the network
of type-II collagen ﬁbres outlining the frame of the cartilage is
ﬁlled with the CSPG gel, it is likely that electrostatic repulsion
by negative charges derived from the large amount of CS in the
wild-type animals prevents the collagen ﬁbres from aggregating
abnormally.
Many hereditary syndromes and idiopathic short stature
patients are characterized by abnormal cartilage development,
including those with PG defects [30]. Some of the hereditary
syndromes and cases of idiopathic short stature might involve
defects in CS synthesis and, more speciﬁcally, genetic errors in
human CSGalNAcT1. We hope that our present study and the
novel genetic model, the CSGalNAcT1-null mice, will contribute
to the clinical investigations of these diseases.
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